Monday, February 20, 2023

Your 7 Day Stock Forecast Toolbox Trial Ends Tomorow...

Your 7-Day Forecast Toolbox Trial is Almost Over!

Thank you for taking the time to Test Drive our Forecast Toolbox.


As with all good things, they must come to an end, and your 7-Day Trial expires tomorrow.

But don't worry, we would like to offer a super discount on the Forecast Toolbox so you can prevent any interruption!
We are excited for you to get started. Drop us an email with questions or feedback any time at support@tradespoon.com.

To great returns,

Vlad Karpel
Tradespoon Founder
 
 
 
 











Tradespoon LLC | 318 Half Day Rd. | Suite 215 | Buffalo Grove | IL | 60089
Unsubscribe From Tradespoon Emails

Disclaimer

As an investor, you know that any kind of investment opportunity has its risks. Past performance is not an indication of future results. There is no such thing as low risk stocks and we recommend you invest wisely. Investing in Stocks and Options is highly speculative. All of the content on our website and in our email alerts is for informational purposes only, and should not be construed as an offer, or solicitation of an offer, to buy or sell securities. Remember, you should always consult with a licensed securities professional before purchasing or selling securities of companies profiled or discussed on Tradespoon.com or in our emails.

Content in this email is provided for informational and educational purposes only.

Vlad and his team may have a financial interest in its picks as they trade many of the same equities and options they pick.

Vlad Karpel and Tradespoon (Company) is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves.

It should not be assumed that the methods, techniques, or indicators developed at Tradespoon will be profitable or that they will not result in losses. nor should it be assumed that future picks will be profitable or will equal past performance.

RISK DISCLOSURE: Options involve substantial risk and are not suitable for all investors. Please read "Characteristics and Risks of Standardized Options " prior to investing in options. Evaluate any strategy prior to use to understand risk and suitability.

No comments:

Post a Comment

Could CVS Health (CVS) Be a Safe Haven as Healthcare Costs Rise?

Healthcare costs in the U.S. are surging, placing significant financial pressure on consumers, insurers, and providers. The growing demand...